Fisioterapia Respiratória
Suplemento | Síndrome da angústia respiratória aguda.
1 Out, 2021 | 20:04hPágina principal: Acute Respiratory Distress Syndrome – Critical Care Clinics
The Epidemiology of Acute Respiratory Distress Syndrome Before and After Coronavirus Disease 2019
Toward Optimal Acute Respiratory Distress Syndrome Outcomes
Pathophysiology of Acute Respiratory Distress Syndrome and COVID-19 Lung Injury
COVID-19–Associated Acute Respiratory Distress Syndrome
Pathophysiology of the Acute Respiratory Distress Syndrome
Acute Kidney Injury and Acute Respiratory Distress Syndrome
Acute Respiratory Distress Syndrome
Fluid Therapy and Acute Respiratory Distress Syndrome
Pharmacologic Treatments for Acute Respiratory Distress Syndrome
Long-Term Outcomes in Acute Respiratory Distress Syndrome
Conteúdos relacionados:
Position paper: Advancing precision medicine for acute respiratory distress syndrome.
Review: Personalized mechanical ventilation in acute respiratory distress syndrome.
Seminar | Acute respiratory distress syndrome.
ARDS: Contemporary management and novel approaches during COVID-19
Revisão sistemática | Caracterização da “long COVID”.
1 Out, 2021 | 19:37hCharacterising long COVID: a living systematic review – BMJ Global Health
Conteúdos relacionados:
Long Covid – The illness narratives.
New guidelines to help doctors manage long COVID patients published.
M-A: More than 50 long-term effects of COVID-19. (vários artigos sobre o tema)
Comentário no Twitter
Our living systematic review on #LongCovid is finally out. It summarises the evidence and will be updated regularly. Free access here: https://t.co/3pxQiB4YEU@louise_sigfrid @mbms_ @laksh_manoharan @ISARIC1 @long_covid @ClaireHastie1 @mbms_ @Know_HG @jakesuett @gail_carson pic.twitter.com/iIbTf8YDQx
— Charitini Stavropoulou (@CharitiniSt) September 27, 2021
Revisão sistemática | Reabilitação pulmonar na doença pulmonar intersticial.
27 Set, 2021 | 13:03hPulmonary rehabilitation for interstitial lung disease – Cochrane Library
Resumo: Pulmonary rehabilitation for interstitial lung disease – Cochrane Library
“Long COVID” – As narrativas da doença.
27 Set, 2021 | 11:32hLong Covid – The illness narratives – Social Science & Medicine
Comentário no Twitter
Our qualitative study of Long Covid was the largest sample (114) published to date. We showed, beyond any reasonable doubt, that this illness is NOT limited to 12 predefined tick-box symptoms. Its key characteristic is 'strangeness' and fluctuation. https://t.co/j6z1u0IYOu pic.twitter.com/C8Hyy9DSms
— Trisha Greenhalgh (@trishgreenhalgh) September 18, 2021
Uso de capacetes no suporte ventilatório não invasivo: uma revisão abrangente dos aspectos técnicos e dos achados clínicos.
17 Set, 2021 | 12:52hDez estratégias para otimizar a mobilização precoce e a reabilitação na terapia intensiva.
12 Set, 2021 | 21:40hTen strategies to optimize early mobilization and rehabilitation in intensive care – Critical Care
Seria hora de abandonar a síndrome de angústia respiratória aguda (SARA)? A lição da COVID-19.
8 Set, 2021 | 15:07hIsn’t it time to abandon ARDS? The COVID-19 lesson – Critical Care
Comentário no Twitter
#CritCare #OA #Gattinoni & #Marini: Keeping or abandoning #ARDS?
▶️ pros
▶️ conshttps://t.co/tIhusXT2S7#FOAMed #FOAMcc #BMC #COVID19 #Rx #RCT #PEEP #respiratory_failure #Personalized pic.twitter.com/M6aoiSAn3m— Critical Care (@Crit_Care) September 7, 2021
“Long COVID”: saúde física e mental de crianças e jovens não hospitalizados depois da infecção por SARS-CoV-2 – 1 em cada 7 crianças pode ainda ter sintomas 15 semanas depois da infecção.
3 Set, 2021 | 11:21hComentários:
Long Covid in children ‘nowhere near scale feared’ – BBC
Conteúdos relacionados:
Cohort study: Risk factors for long covid in previously hospitalized children.
M-A: More than 50 long-term effects of COVID-19.
Comentário no Twitter (fio – clique para saber mais)
The worlds biggest study of post acute #COVID19 symptoms in children is out as a pre-print – the CLoCK study!
Fortunately results are very reassuring regarding symptom frequency and impact
Some important lessons, let's take a look 🧵
— Alasdair Munro (@apsmunro) September 1, 2021
Estudo randomizado | Entre pacientes criticamente doentes, a meta de oxigenação em um intervalo normal baixo vs. intervalo normal alto não resultou em redução na disfunção de órgãos.
3 Set, 2021 | 11:12hEffect of Low-Normal vs High-Normal Oxygenation Targets on Organ Dysfunction in Critically Ill Patients: A Randomized Clinical Trial – JAMA (gratuito por tempo limitado)
Conteúdos relacionados:
M-A of randomized trials: Conservative oxygen therapy for critically ill patients.
Oxygen administration for patients with ARDS – Journal of Intensive Care
Comentário no Twitter
Multicenter RCT found, among critically ill patients, targeting oxygenation to a low-normal range compared with a high-normal range did not result in a statistically significant reduction in organ dysfunction https://t.co/lEq28bqmM4 #ISICEM21
— JAMA (@JAMA_current) August 31, 2021
Estudo randomizado | Em pacientes com insuficiência respiratória hipoxêmica, uma estratégia de ventilação com volume corrente mais baixo, facilitada pela remoção extracorpórea de dióxido de carbono, não foi associada com desfechos melhores.
3 Set, 2021 | 11:10hEffect of Lower Tidal Volume Ventilation Facilitated by Extracorporeal Carbon Dioxide Removal vs Standard Care Ventilation on 90-Day Mortality in Patients With Acute Hypoxemic Respiratory Failure: The REST Randomized Clinical Trial – JAMA (gratuito por tempo limitado)
Conteúdo relacionado: Randomized Trial: Low vs Intermediate Tidal Volume Strategy in ICU Patients Without ARDS
Comentário no Twitter
In this randomized clinical trial that included 412 adults, 90-day mortality was 41.5% in the extracorporeal carbon dioxide removal group and 39.5% in the standard care group, a difference that was not statistically significant https://t.co/jhCY2r4qjX #ISICEM21
— JAMA (@JAMA_current) August 31, 2021